Phosphorylation of PKCδ by FER tips the balance from EGFR degradation to recycling

Autor: Leila Belle, Gregory J. Goodall, Xiaochun Li, Nicole L. Schieber, Elizabeth V. Nguyen, Freya Gehling, Ana Lonic, Yeesim Khew-Goodall, Roger J. Daly, Robert G. Parton
Přispěvatelé: Lonic, Ana, Gehling, Freya, Belle, Leila, Li, Xiaochun, Schieber, Nicole L, Nguyen, Elizabeth V, Goodall, Gregory J, Parton, Robert G, Daly, Roger J, Khew-Goodall, Yeesim
Rok vydání: 2021
Předmět:
Time Factors
Endosome
Cell
Breast Neoplasms
Endosomes
Biology
environment and public health
Article
Receptor tyrosine kinase
03 medical and health sciences
0302 clinical medicine
trafficking
Cell Line
Tumor

Lysosome
medicine
Humans
cancer
RNA
Messenger

Phosphorylation
Extracellular Signal-Regulated MAP Kinases
Phosphotyrosine
Late endosome
Cancer
030304 developmental biology
0303 health sciences
Trafficking
Epidermal Growth Factor
Protein Stability
Cell growth
Ubiquitination
Cell Biology
Protein-Tyrosine Kinases
Protein Tyrosine Phosphatases
Non-Receptor

Endocytosis
Cell biology
Enzyme Activation
ErbB Receptors
enzymes and coenzymes (carbohydrates)
Protein Kinase C-delta
Protein Transport
medicine.anatomical_structure
rab GTP-Binding Proteins
030220 oncology & carcinogenesis
Proteolysis
biology.protein
Female
Mitogens
Tyrosine kinase
Zdroj: The Journal of Cell Biology
ISSN: 1540-8140
0021-9525
DOI: 10.1083/jcb.201902073
Popis: Lonic et al. show that phosphorylation of Y374-PKCδ by FER arrests the maturation of early to late endosomes by inhibiting the release of RAB5 from nascent late endosomes. This promotes EGFR recycling and sustained signaling in triple-negative breast cancer.
Receptor degradation terminates signaling by activated receptor tyrosine kinases. Degradation of EGFR occurs in lysosomes and requires the switching of RAB5 for RAB7 on late endosomes to enable their fusion with the lysosome, but what controls this critical switching is poorly understood. We show that the tyrosine kinase FER alters PKCδ function by phosphorylating it on Y374, and that phospho-Y374-PKCδ prevents RAB5 release from nascent late endosomes, thereby inhibiting EGFR degradation and promoting the recycling of endosomal EGFR to the cell surface. The rapid association of phospho-Y374-PKCδ with EGFR-containing endosomes is diminished by PTPN14, which dephosphorylates phospho-Y374-PKCδ. In triple-negative breast cancer cells, the FER-dependent phosphorylation of PKCδ enhances EGFR signaling and promotes anchorage-independent cell growth. Importantly, increased Y374-PKCδ phosphorylation correlating with arrested late endosome maturation was identified in ∼25% of triple-negative breast cancer patients, suggesting that dysregulation of this pathway may contribute to their pathology.
Databáze: OpenAIRE